Belmac
This article was originally published in The Tan Sheet
Executive Summary
President and CEO Michael Harshbarger, whose term ran for five months, leaves the firm. In February, Belmac accepted the resignations of Chairman and CEO Jean-Francoise Rossignol, Chief Financial Officer Max Huguet and Senior VP Vittorio Ferraris. The Tampa-based company has not appointed a replacement for Harshbarger, but said that the post is being discussed with a candidate with a "strong" pharmaceutical background.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning